Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 5,576–5,600 of 7,816 matching trials · page 224 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Follow-up Measurement of Brain PDE10A Enzyme Levels in Huntington´s Disease Gene Expansion Carriers NCT02956148 Radioligand [18F]MNI-659 Runs in: Denmark; Netherlands; Norway; Sweden · 7 sites |
EARLY_PHASE1 other |
COMPLETED | 45 | CHDI Foundation, Inc. OTHER |
2019-10-10 |
|
Cerebrovascular Correlates of Dementia in Rural Communities - The Three Villages Study NCT04123171 Neuroimaging studies Runs in: Ecuador · 2 sites |
NA other |
UNKNOWN | 600 | Universidad de Especialidades Espiritu Santo OTHER |
2019-10-10 |
|
Valproic Acid in Subjects With Intact Cognition - Proof of Concept Study NCT01729598 Valproic Acid; Placebo Runs in: United States · 1 site |
EARLY_PHASE1 other |
COMPLETED | 14 | Gregory Jicha, 323-5550 OTHER |
2019-10-09 |
|
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo NCT01900665 Solanezumab; Placebo Runs in: Australia; Canada; France; Germany; Italy; Japan; Poland;... · 198 sites |
PHASE3 anti-amyloid-antibody |
TERMINATED | 2,129 | Eli Lilly and Company INDUSTRY |
2019-10-09 |
|
Early Detection and Prevention of Mild Cognitive Impairment Due to Cerebrovascular Disease NCT01924312 Heart Health Intervention Runs in: United States · 1 site |
NA other |
COMPLETED | 80 | Gregory Jicha, 323-5550 OTHER |
2019-10-09 |
|
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease NCT01127633 Solanezumab; Placebo Runs in: Argentina; Australia; Brazil; Canada; France; Germany; It... · 147 sites |
PHASE3 anti-amyloid-antibody |
TERMINATED | 1,457 | Eli Lilly and Company INDUSTRY |
2019-10-08 |
|
Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease NCT02045056 Gemfibrozil; Placebo Runs in: United States · 1 site |
EARLY_PHASE1 other |
COMPLETED | 72 | Gregory Jicha, 323-5550 OTHER |
2019-10-08 |
|
Genetic Evaluation for Medication Selection (GEMS) Study NCT03736057 Delayed results of pharmacogenomic results Runs in: United States · 1 site |
NA other |
COMPLETED | 40 | University of Alabama at Birmingham OTHER |
2019-10-07 |
|
COgilus Remediation in Alzheimer Patients (CORA) NCT04113577 usability survey Runs in: France · 1 site |
NA other |
UNKNOWN | 120 | University Hospital, Angers OTHER_GOV |
2019-10-04 |
|
Feasibility and Efficacy of Dietary Interventions for Older Adults With Subjective Cognitive Decline NCT03585907 MAD; MIND |
NA other |
WITHDRAWN | 0 | Johns Hopkins University OTHER |
2019-10-03 |
|
Efficacy of a Biodanza Program in People With Alzheimer's Disease. NCT04113967 Biodanza program Runs in: Spain · 1 site |
NA other |
COMPLETED | 40 | Universidad de Almeria OTHER |
2019-10-03 |
|
Vision-based Speed of Processing Cognitive Training and Mild Cognitive Impairment NCT02559063 Vision-based speed of processing training; Mental leisure activities Runs in: United States · 1 site |
NA other |
COMPLETED | 84 | University of Rochester OTHER |
2019-10-02 |
|
Auditory Intraoperative Stimulation Effects on Pain and Agitation at Awakening (AUDIOPAW) NCT04112979 Music; Mother's lap; Soundproof earplugs Runs in: Italy · 1 site |
NA other |
COMPLETED | 115 | IRCCS Burlo Garofolo OTHER |
2019-10-02 |
|
A Prospective Observational Trial to Determine Cardiovascular Diseases in HIV-infected Patients NCT02291081 Comprehensive non invasive cardiovascular examination Runs in: Germany · 7 sites |
NA other |
COMPLETED | 1,519 | University Hospital, Essen OTHER |
2019-10-01 |
|
The Effect of Nimodipine on the Postoperative Cognitive Dysfunction NCT02537080 Nimodipine group; Control group Runs in: Czechia · 1 site |
NA other |
TERMINATED | 15 | University Hospital Hradec Kralove OTHER |
2019-10-01 |
|
A Study to Assess Safety, Tolerability, and Efficacy of HTL0018318 in Patients With Dementia With Lewy Bodies NCT03592862 HTL0018318; Placebo Runs in: Japan · 3 sites |
PHASE2 other |
WITHDRAWN | 0 | Nxera Pharma UK Limited INDUSTRY |
2019-10-01 |
|
Computerized Cognitive Training in Neurodegenerative Diseases (NDD2019) NCT04111640 CoRe software; Control Group Runs in: Italy · 1 site |
NA other |
UNKNOWN | 40 | IRCCS National Neurological Institute "C. Mondino" Foundation OTHER |
2019-10-01 |
|
Improving Adherence Healthy Lifestyle With a Smartphone Application Based on Adults With Intellectual Disabilities NCT01915381 multimodal intervention Runs in: Spain · 1 site |
NA other |
COMPLETED | 40 | University of Malaga OTHER |
2019-09-30 |
|
Clinical Effect Size of an Educational Intervention in the Home and Compliance on People Who Suffer From Stroke NCT01980641 Educational intervention; Smartphone-based application Runs in: Spain · 2 sites |
NA other |
COMPLETED | 34 | University of Malaga OTHER |
2019-09-30 |
|
Deep Brain Stimulation (DBS) for Alzheimer's Disease NCT00658125 Bilateral fornix DBS implantation, Runs in: Canada · 1 site |
NA other |
COMPLETED | 6 | University Health Network, Toronto OTHER |
2019-09-27 |
|
Mild Cognitive Impairment, Buddy Supported Exercise/ My Buddy Study NCT01561820 5-month aerobic exercise intervention Runs in: United States · 1 site |
NA other |
COMPLETED | 15 | Wake Forest University OTHER |
2019-09-26 |
|
Alzheimer's Caregiver Coping: Mental and Physical Health NCT02317523 Behavioral Activation; Information and Support Runs in: United States · 1 site |
NA other |
COMPLETED | 151 | University of California, San Diego OTHER |
2019-09-26 |
|
Early Intervention Programme for Young Patients (Aged 15 - 30 Years) With Symptoms Following Concussion. NCT02337101 Enhanced Usual Care (EUC); EUC + Early intervention programme Runs in: Denmark · 1 site |
NA other |
COMPLETED | 120 | University of Aarhus OTHER |
2019-09-26 |
|
Benefits of Exercise in Alzheimer's Disease NCT01935024 Personalized Exercise Regimen Runs in: Canada · 1 site |
NA other |
UNKNOWN | 60 | University Health Network, Toronto OTHER |
2019-09-25 |
|
Personalized Music Therapy and Agitation in Dementia NCT02147652 Personalized music |
NA other |
UNKNOWN | 60 | University Health Network, Toronto OTHER |
2019-09-25 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial